Refresh plus 0.5% 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FHZC5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,495
Award facts
- Contract value 100% obligated
- $2,494.80 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,494.80 to DMS Pharmaceutical Group Inc. for Refresh Plus 0.5% ophthalmic solution (30-count packaging) on February 4, 2026. This firm fixed-price delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense medical facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $500 million ceiling and completion date of December 31, 2036. The PPV-G GEN V contract represents part of the broader $30.3 billion acquisition strategy designed to supply branded and generic prescription drugs, biologics, medical consumables, and specialized pharmaceuticals to support Department of Defense healthcare operations globally. As a regional prime vendor contractor, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity through numerous delivery orders spanning diverse therapeutic categories and product lines since late 2025.
Quick answers
Who was awarded contract SPE2DR26FHZC5?
SPE2DR26FHZC5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FHZC5 worth?
The government has obligated $2,495 on SPE2DR26FHZC5.
Is contract SPE2DR26FHZC5 an order under another contract?
Yes. SPE2DR26FHZC5 is a delivery order under SPE2DR25D9762, an indefinite delivery contract.
Was contract SPE2DR26FHZC5 competed?
The extent of competition for SPE2DR26FHZC5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award